A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1997
12/18/1997	WO1997047298A1 Therapeutic treatment for cardiovascular diseases
12/18/1997	WO1997035982A3 Monocyte chemotactic protein-5 materials and methods
12/18/1997	WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
12/18/1997	CA2257693A1 Therapeutic treatment for cardiovascular diseases
12/18/1997	CA2257275A1 New substituded 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them
12/18/1997	CA2256459A1 T-cell selective interleukin-4 agonists
12/18/1997	CA2207886A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
12/17/1997	EP0812844A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
12/17/1997	EP0812841A1 Crystal of N-((quinolin-2-yl)-phenyl)sulfonamides and process for producing the same
12/17/1997	EP0812835A1 Optically active thiazolidinone derivatives
12/17/1997	EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists
12/17/1997	EP0812197A2 Use of moxonidine for the treatment of atherosclerosis
12/17/1997	EP0812190A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
12/17/1997	EP0698025B1 Ampa antagonists and a method of treatment therewith
12/17/1997	EP0549729B1 Antiviral compounds and antihypertensive compounds
12/17/1997	EP0275249B2 Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments
12/17/1997	CN1168142A Novel peptides, their production and use
12/17/1997	CN1168137A Pyridazinones as endothelin-receptor antagonists
12/17/1997	CN1167763A Acids and esters of diosmetin and pharmaceutical compositions containing them
12/17/1997	CN1167759A Substd. 2-naphthoyl guanidines, their preparing method, use and drug contg. them
12/17/1997	CN1167758A Substd. 1-naphthoyl guanidines, their preparing method, use and drug contg. them
12/17/1997	CN1167610A Compound hypotensive hair-protective liquid and its preparing method
12/16/1997	US5698733 Use of 9-deoxy prostaglandin derivatives to treat glaucoma
12/16/1997	US5698706 Heterocyclic amides and methods of use
12/16/1997	US5698690 Hydroxamic acid derivatives with tricyclic substitution
12/16/1997	US5698596 Substituted benzenesulfonylureas and thioureas process for their preparation and their use as pharmaceuticals
12/16/1997	US5698594 Treatment and prevention of risk factors for cardiovascular diseases
12/16/1997	US5698589 Water-based topical cream containing nitroglycerin and method of preparation and use thereof
12/16/1997	US5698581 Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
12/16/1997	US5698578 Protein kinase C inhibitors
12/16/1997	US5698566 Nitrogen-containing spirocycles
12/16/1997	US5698561 Medicament for treating or preventing cerebrovascular dementia
12/16/1997	US5698553 Nervous system disorders
12/16/1997	US5698552 Hetrazepinoid amides
12/16/1997	US5698548 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
12/16/1997	US5698535 SIN-1A cyclodextrin inclusion complexes
12/16/1997	US5698526 Anticholesterol agent
12/16/1997	US5698517 Thyroxin-binding HSA fragments
12/16/1997	US5698405 Coupling immunogenic agent with a carbohydrate polymer
12/16/1997	US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies
12/13/1997	CA2207464A1 Crystal of n-{(quinolin-2-yl)phenylsulfonamides and process for producing the same
12/11/1997	WO1997046671A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	WO1997046579A1 Neuropeptide y agonists
12/11/1997	WO1997046565A1 SELECTED DERIVATIVES OF K-252a
12/11/1997	WO1997046551A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/11/1997	WO1997046522A1 Novel vitamin d analogues
12/11/1997	WO1997046251A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
12/11/1997	WO1997046241A1 Formulation and method for treating congestive heart failure
12/11/1997	WO1997046238A1 Medicaments for ameliorating endothelial cell activation
12/11/1997	WO1997046233A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
12/11/1997	WO1997046226A2 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
12/11/1997	CA2257424A1 Neuropeptide y agonists
12/11/1997	CA2257299A1 Use of inhibitors of the cellular na+/h+ exchanger (nhe) for production of a medicament for the normalization of serum lipids
12/11/1997	CA2256720A1 Formulation and method for treating congestive heart failure
12/11/1997	CA2256653A1 Use of raloxifene and of related compounds for the manufacture of a medicament for lowering plasma levels of lipoprotein(a)
12/11/1997	CA2256456A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	CA2256449A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/10/1997	EP0811686A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811685A2 Human platelet-derived growth factor receptors
12/10/1997	EP0811623A1 Xanthine derivatives with end-aminated alkynol side chains
12/10/1997	EP0811621A2 Carbamoyl substituted oxazoles as thromboxane receptor antagonists
12/10/1997	EP0811616A1 Salts of 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl-propionic acid ethylester
12/10/1997	EP0811610A1 Ortho-substituted benzoylguanidines process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/10/1997	EP0811380A2 Use of vanadiumcompositions for lowering blood sugar levels
12/10/1997	EP0811008A1 Bicyclic benzazepine derivatives as vasopressin antagonists
12/10/1997	EP0811001A1 Benzothiazine dioxides as endothelin antagonists
12/10/1997	EP0810991A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
12/10/1997	EP0810884A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
12/10/1997	EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1036652C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
12/10/1997	CN1036651C Method for prepn. of carbostyril derivatives
12/09/1997	US5696167 4-mercaptobenzoylguanidine derivatives
12/09/1997	US5696152 Taxol composition for use as organ preservation and cardioplegic agents
12/09/1997	US5696147 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
12/09/1997	US5696145 Vasopressin and oxytocin receptor
12/09/1997	US5696141 Isoxazoline compounds as 5-lipoxygenase inhibitors
12/09/1997	US5696138 Urea derivatives and their use
12/09/1997	US5696137 Azaheterocyclymethyl-chromans
12/09/1997	US5696136 Method of treating psychosis using azaheterocyclylmethyl
12/09/1997	US5696129 5-HT4 antagonists
12/09/1997	US5696124 Xanthine derivatives with adenosine-antagonistic activity
12/09/1997	US5696122 Indole and indoline derivatives as 5HT1D receptor antagonists
12/09/1997	US5696116 Pharmaceutical composition which contains a renin angiotensin system inhibitor and an endothelin antagonist
12/09/1997	US5696112 Fused heterocyclic azepines as vasopressin antagonists
12/09/1997	US5696111 Antiarrhythmic agents
12/09/1997	US5696108 Protein kinase C inhibitors
12/09/1997	US5696100 Anticancer agent
12/09/1997	US5695953 DNA that encodes a tumor necrosis factor inhibitory protein and a recombinant method of production
12/09/1997	US5695796 Fermented milk product
12/09/1997	US5695753 Transglutaminases as immunosuppressants
12/09/1997	CA1339573C Pyrimido¬4,5-d\| pyrimidine derivatives for use as bronchodilators
12/04/1997	WO1997045450A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy
12/04/1997	WO1997045425A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
12/04/1997	WO1997045417A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/04/1997	WO1997045409A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/04/1997	WO1997045402A1 Phenylsulfonamide derivatives
12/04/1997	WO1997045397A1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
12/04/1997	WO1997045131A1 Compositions for use in embolizing blood vessels
12/04/1997	WO1997045115A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders

1 ... 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 ... 1595